Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 18
1966 43
1967 78
1968 108
1969 83
1970 103
1971 126
1972 165
1973 172
1974 214
1975 226
1976 230
1977 215
1978 198
1979 171
1980 182
1981 161
1982 211
1983 175
1984 198
1985 236
1986 196
1987 217
1988 224
1989 240
1990 266
1991 241
1992 276
1993 227
1994 286
1995 326
1996 328
1997 300
1998 312
1999 373
2000 356
2001 410
2002 420
2003 443
2004 455
2005 446
2006 558
2007 644
2008 757
2009 777
2010 897
2011 917
2012 856
2013 772
2014 733
2015 725
2016 700
2017 688
2018 690
2019 704
2020 790
2021 784
2022 731
2023 633
2024 802
2025 755
2026 422

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22,942 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma.
Shi GM, Huang XY, Liang F, Liang X, Dong R, Ye QH, Gao Q, Ji Y, Yu ZP, Zhai WL, Lu JC, Li XW, Liu FB, Wang K, Yang W, Zhang JL, Hu ZQ, Qiu SJ, Wang XY, Yang XR, Sun HC, Shi YH, Ding ZB, Liu WR, Huang XW, Huang C, Shen YH, Sun J, He YF, Peng YF, Xu Y, Zou JJ, Zhou J, Fan J; ZSAB Study Group. Shi GM, et al. N Engl J Med. 2026 Mar 5;394(10):983-995. doi: 10.1056/NEJMoa2513918. N Engl J Med. 2026. PMID: 41780001 Clinical Trial.
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer.
Sinicrope FA, Ou FS, Arnold D, Peters WR, Behrens RJ, Lieu CH, Matin K, Cohen DJ, Potter SL, Nixon AB, Kottschade LA, Kathol E, Frankel WL, Shergill A, Hsu D, Reinacher-Schick A, Mehan P, Gold PJ, Khalil MF, Zemla T, Gatten C, O'Reilly EM, Meyerhardt JA. Sinicrope FA, et al. N Engl J Med. 2026 Mar 26;394(12):1155-1166. doi: 10.1056/NEJMoa2507874. N Engl J Med. 2026. PMID: 41880612 Free PMC article. Clinical Trial.
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial.
Janssen QP, van Dam JL, van Bekkum ML, Bonsing BA, Bos H, Bosscha KP, Bouwense SAW, Brouwer-Hol L, Bruynzeel AME, Busch OR, Coene PLO, van Eijck CHJ, de Groot JWB, Haberkorn BCM, de Hingh IHJT, Karsten TM, Kazemier G, van der Kolk MB, Liem MSL, Loosveld OJL, Luelmo SAC, Luyer MDP, Mekenkamp LJM, Mieog JSD, Nieuwenhuijs VB, Nuyttens JJME, Patijn GA, van Santvoort HC, Stommel MWJ, Versteijne E, de Vos-Geelen J, de Wilde RF, Zonderhuis BM, van der Holt B, Homs MYV, van Tienhoven G, Besselink MG, Wilmink JW, Groot Koerkamp B; Dutch Pancreatic Cancer Group. Janssen QP, et al. Lancet Oncol. 2025 Oct;26(10):1346-1356. doi: 10.1016/S1470-2045(25)00363-8. Epub 2025 Sep 10. Lancet Oncol. 2025. PMID: 40945523 Clinical Trial.
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study.
Shen L, Zhang X, Ji K, Lu L, Wang Q, Guan Q, Yan S, Zhou Y, Yang Y, Huo Z, You J, Ba Y, Ye Y, Chen Y, Wang S, Lv G, Zhang J, Hu X, Yang F, Yu H, Li J, Wang Q, Zhu J, Ji J; ASTRUM-006 Study Group. Shen L, et al. Lancet. 2026 Jun 20;407(10547):2542-2553. doi: 10.1016/S0140-6736(26)00974-8. Epub 2026 Jun 1. Lancet. 2026. PMID: 42225112 Clinical Trial.
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Knox JJ, O'Kane G, King D, Laheru D, Habowski AN, Yu K, Perez K, Aguirre AJ, Coyne Z, Harvey H, McLaughlin RA, Jang RW, Grant RC, Elimova EC, Renouf DJ, Fischer S, Duan K, Ramotar S, Jang GH, Zhang A, Devoe CE, Singh H, Pishvaian MJ, Froeling FEM, Saif MW, O'Reilly EM, Tsang ES, Wolpin BM, Wilson JM, Dodd A, Pugh TJ, Ye XY, Gallinger S, Tuveson DA, Notta F, Jaffee EM. Knox JJ, et al. J Clin Oncol. 2025 Nov;43(31):3355-3368. doi: 10.1200/JCO-25-00436. Epub 2025 Sep 10. J Clin Oncol. 2025. PMID: 40929627 Clinical Trial.
Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial.
Yuan J, Bi XW, Hua X, Huang H, Cai L, Zhao L, Chen QJ, Chen XX, Wang XL, Lin Y, Zhang AQ, Zhong YY, Xu F, Huang JJ, An X, Shi YX, Wang X, Wang SS, Xue C, Yuan ZY. Yuan J, et al. Lancet Oncol. 2025 Dec;26(12):1575-1583. doi: 10.1016/S1470-2045(25)00545-5. Lancet Oncol. 2025. PMID: 41308674 Clinical Trial.
Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603.
Kanemitsu Y, Shimizu Y, Mizusawa J, Inaba Y, Tsukamoto S, Takashima A, Ohue M, Komori K, Shiomi A, Shiozawa M, Suwa Y, Suto T, Kinugasa Y, Takii Y, Bando H, Kobatake T, Inomata M, Shimada Y, Katayama H, Fukuda H; JCOG Colorectal Cancer Study Group. Kanemitsu Y, et al. J Clin Oncol. 2026 May 20;44(15):1395-1400. doi: 10.1200/JCO-25-01231. Epub 2026 Jan 21. J Clin Oncol. 2026. PMID: 41564372 Free PMC article. Clinical Trial.
Neoadjuvant Chemotherapy vs Upfront Surgery in Patients With Locally Advanced Colon Cancer: A Randomized Clinical Trial.
Jensen LH, Kjaer M, Diness LV, Hollânder NH, Rahr HB, Pfeffer F, Larsen FO, Lindebjerg J, Rafaelsen SR, Hansen TF, Timm S, Løes IM, Gögenur I, Zitnjak D, Andersen F, Petersen LN, Lindskog EB, Poulsen LØ, Dahl O. Jensen LH, et al. JAMA Surg. 2026 May 1;161(5):450-458. doi: 10.1001/jamasurg.2026.0085. JAMA Surg. 2026. PMID: 41779406 Clinical Trial.
22,942 results
You have reached the last available page of results. Please see the User Guide for more information.